An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Caris data tie its AI-guided therapy recommendations to longer survival in pancreatic cancer patients.
Japanese bio-AI startup Craif banks $33M to push its urine-based pancreatic cancer test toward US launch.
AI screening of nearly 40,000 compounds produced a GIPC1 inhibitor that slowed pancreatic tumor growth in preclinical models.